Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing combination chemotherapy with or without trastuzumab in women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED